1,2-distearoyllecithin has been researched along with lactic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Feuerstein, G; Ligler, FS; Rabinovici, R; Rudolph, AS; Smith, EF | 1 |
Cohen, O; Cordfunke, RA; de Boer, L; de Breij, A; Drijfhout, JW; Emanuel, N; Kwakman, PH; Moriarty, TF; Nibbering, PH; Riool, M; Zaat, SA | 1 |
2 other study(ies) available for 1,2-distearoyllecithin and lactic acid
Article | Year |
---|---|
Biological responses to exchange transfusion with liposome-encapsulated hemoglobin.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Pressure; Blood Substitutes; Exchange Transfusion, Whole Blood; Heart Rate; Hemoglobins; Lactates; Lactic Acid; Liposomes; Male; Phosphatidylcholines; Rats; Rats, Inbred Strains; Sodium Chloride; Thromboxane B2 | 1992 |
Prevention of Staphylococcus aureus biomaterial-associated infections using a polymer-lipid coating containing the antimicrobial peptide OP-145.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Biofilms; Cholesterol; Female; Lactic Acid; Mice, Inbred C57BL; Nail Diseases; Phosphatidylcholines; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prostheses and Implants; Rabbits; Silicones; Staphylococcal Infections; Staphylococcus aureus | 2016 |